Literature DB >> 16790587

DMT1 mutation: response of anemia to darbepoetin administration and implications for iron homeostasis.

Dagmar Pospisilova, Martha P Mims, Elizabeta Nemeth, Tomas Ganz, Josef T Prchal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16790587      PMCID： PMC1895846          DOI： 10.1182/blood-2006-02-003962

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cells.

Authors:  Monika Priwitzerova; Dagmar Pospisilova; Josef T Prchal; Karel Indrak; Alice Hlobilkova; Vladimir Mihal; Prem Ponka; Vladimir Divoky
Journal:  Blood       Date:  2004-05-15       Impact factor: 22.113

2.  Analysis of the E399D mutation in SLC11A2.

Authors:  Hiromi Gunshin; Jie Jin; Yuko Fujiwara; Nancy C Andrews; Martha Mims; Josef Prchal
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

3.  Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload.

Authors:  Carole Beaumont; Jean Delaunay; Gilles Hetet; Bernard Grandchamp; Mariane de Montalembert; Gil Tchernia
Journal:  Blood       Date:  2006-01-26       Impact factor: 22.113

4.  Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake.

Authors:  Monika Priwitzerova; Guangjun Nie; Alex D Sheftel; Dagmar Pospisilova; Vladimir Divoky; Prem Ponka
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

5.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

6.  Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs.

Authors:  Seth Rivera; Elizabeta Nemeth; Victoria Gabayan; Miguel A Lopez; Dina Farshidi; Tomas Ganz
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

7.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

8.  Hepcidin in iron overload disorders.

Authors:  George Papanikolaou; Michalis Tzilianos; John I Christakis; Dionisios Bogdanos; Konstantina Tsimirika; Julie MacFarlane; Y Paul Goldberg; Nikos Sakellaropoulos; Tomas Ganz; Elizabeta Nemeth
Journal:  Blood       Date:  2005-01-25       Impact factor: 22.113

9.  Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.

Authors:  Martha P Mims; Yongli Guan; Dagmar Pospisilova; Monika Priwitzerova; Karel Indrak; Prem Ponka; Vladimir Divoky; Josef T Prchal
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

10.  Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2).

Authors:  Achille Iolascon; Maria d'Apolito; Veronica Servedio; Flora Cimmino; Antonio Piga; Clara Camaschella
Journal:  Blood       Date:  2005-09-13       Impact factor: 22.113
  10 in total
  6 in total

1.  New Cases of Hypochromic Microcytic Anemia Due to Mutations in the SLC11A2 Gene and Functional Characterization of the G75R Mutation.

Authors:  Lídia Romero-Cortadellas; Gonzalo Hernández; Xènia Ferrer-Cortès; Laura Zalba-Jadraque; José Luis Fuster; Mar Bermúdez-Cortés; Ana María Galera-Miñarro; Santiago Pérez-Montero; Cristian Tornador; Mayka Sánchez
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

Review 2.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.

Authors:  Achille Iolascon; Luigia De Falco; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

3.  Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts.

Authors:  Monika Horvathova; Katarina Kapralova; Zuzana Zidova; Dalibor Dolezal; Dagmar Pospisilova; Vladimir Divoky
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

4.  Hematopoietic-specific Stat5-null mice display microcytic hypochromic anemia associated with reduced transferrin receptor gene expression.

Authors:  Bing-Mei Zhu; Sara K McLaughlin; Risu Na; Jie Liu; Yongzhi Cui; Cyril Martin; Akiko Kimura; Gertraud W Robinson; Nancy C Andrews; Lothar Hennighausen
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

5.  The Short Tandem Repeat of the DMT1 Gene as a Molecular Marker of Elite Long-Distance Runners.

Authors:  Gerile Wuyun; Yang Hu; Zihong He; Yanchun Li; Xu Yan
Journal:  Int J Genomics       Date:  2019-11-23       Impact factor: 2.326

6.  Hepcidin contributes to Swedish mutant APP-induced osteoclastogenesis and trabecular bone loss.

Authors:  Hao-Han Guo; Lei Xiong; Jin-Xiu Pan; Daehoon Lee; Kevin Liu; Xiao Ren; Bo Wang; Xiao Yang; Shun Cui; Lin Mei; Wen-Cheng Xiong
Journal:  Bone Res       Date:  2021-06-09       Impact factor: 13.567
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.